Introduction
Giant cell arteritis is known to affect various intracranial and extracranial arteries. It usually presents with headaches, weight loss and visual symptoms, and other complications may be revealed later during its course. Intra-cranial involvement is infrequent and endocrine abnormality as a complication is rare. I present a case of giant cell arteritis presenting with diabetes insipidus. To A diagnosis of cranial diabetes insipidus was made and therapy with desmopressin was commenced, initially 10 jg twice daily intranasally. Symptoms dramatically improved and urine osmolality increased to 660-810 mosmol/kg. The ESR remained at 112mm/h when she was discharged in May, 1986 on desmopressin 15,g twice daily.
In July 1986 she complained of severe deterioration in vision for 2 weeks. She had no headaches or neuromuscular symptoms. The blood pressure was unchanged. The temporal arteries were still pulsatile and non-tender. She could count fingers at 1 yard with the right eye but, with the left, only perception of light was possible. No visual field defects were noted. The optic discs were pale and swollen with haemorrhages near the discs in both the eyes. The ESR remained at 100mm/h, and cranial computerized tomogram was similar to the previous one. Temporal arteritis was diagnosed and confirmed by temporal artery biopsy which showed focal infiltration by lymphocytes and histiocytes with degeneration of the elastica. Prednisolone 60mg/day was commenced and later was gradually reduced. Vision markedly improved and the ESR dropped to 12mm/h over the following few weeks.
In December 1986 the water deprivation test was repeated. Desmopressin was discontinued 20 days before the test. Urine osmolality was 200mosmol/ kg before, 732 mosmol/kg (with serum osmolality 301 mosmol/kg) after 8 hours' water deprivation and 850 mosmol/kg after pitressin tannate injection.
She has been followed up and has had no recurrence of symptoms related to diabetes insipidus but still has some residual defect of visual acuity. The random urinary osmolality was 431 mosmol/kg in early 1987 without desmopressin therapy.
Discussion
After 8 hours' strict water deprivation the patient became confused and agitated. Though there was only marginal increase in plasma osmolality the test could not be prolonged because of her poor clinical state. However, the dilute urine after water deprivation with a marked [threefold] increase in urine osmolality after desmopressin and the dramatic improvement in her symptoms and urinary concentration on desmopressin therapy confirmed the diagnosis of cranial diabetes insipidus. Clinical findings and investigations in this case did not suggest any known causes of diabetes insipidus such as granulomas, neoplasia, or cerebral haemorrhage involving hypothalamic-pituitary area. Reversal of urinary concentration to normal, while she was off desmopressin therapy could have been due to improvement in the underlying pathology following steroid therapy. Therefore it is most likely that diabetes insipidus in this case was caused by giant cell arteritis of the vessels supplying the hypothalamic hypopituitary area.
Giant cell arteritis infrequently involves various intracranial arteries. Caselli et al.1 discussed the neurological problems caused by the involvement of intracranial arteries in biopsy-proven giant cell arteritis. Transient ischaemic attacks and strokes were reported in 7% of cases and neuroophthalmological problems in 21% of the patients with biopsy-proven giant cell arteritis. Tang and Hollenhorst2 3 separately discussed different ophthalmoscopic findings in giant cell arteritis and the funduscopic findings in this case fit in with changes caused by ischaemic optic neuropathy. Local vasculitis or granulomatosis of hypothalamicpituitary area was thought to be responsible in these cases. Some of these cases have responded to the treatment of Wegener's granulomatosis with cyclophosphamide. To my knowledge no case of cranial diabetes insipidus due to giant cell arteritis has so far been documented.
Comment
This case of temporal arteritis is of interest in its association and presentation with diabetes insipidus. It also shows that endocrine dysfunction may be transient and may improve by treating the underlying pathology, giant cell arteritis. It emphasizes the importance that physicians should be aware of the possibility of pituitary dysfunction among other intracranial involvements in giant cell arteritis.
